ProVerum Medical
PrivateLast Round
Series B
Aug 25, 2025
Total Funding Raised
$124.7M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
ProVerum Medical is a medical device company that develops minimally invasive technologies for the treatment of benign prostatic hyperplasia.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
ProVerum Medical Comparables
Compare ProVerum Medical with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Zenflow | 93% | |
| Butterfly Medical | 92% | |
| Rivermark Medical | 87% |
ProVerum Medical Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Aug 25, 2025 | ||||
| Grant | Mar 8, 2025 | ||||
| Series A | Jan 11, 2022 | ||||
| Grant | Mar 12, 2020 | ||||
| Seed | Jul 12, 2018 |
Key People
Founding team and executive leadership
ProVerum Medical Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Atlantic Bridge Capital | Series A, Series B |
| Lightstone Ventures | Series B, Series A |
| OrbiMed | Series B |
| Gilde Healthcare | Series B, Series A |
| Disruptive Technologies Innovation Fund | Grant |
| Irrus Investments | Seed |
| National Treasury Management Agency | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 28, 2026
Open roles increased to 17, 29% of headcount.
- Sep 14, 2026
Open roles increased to 12, 3.2x the trailing average.
ProVerum Medical Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about ProVerum Medical's valuation, stock price, and market status.
Is ProVerum Medical a public or private company?
ProVerum Medical is a private company.
What is the current stock price of ProVerum Medical?
ProVerum Medical is a private company with no public stock price. No recent secondary market data is available.
How much is ProVerum Medical worth (valuation)?
Valuation information for ProVerum Medical is not publicly available.
Can I buy ProVerum Medical stock?
ProVerum Medical shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was ProVerum Medical's last funding round?
ProVerum Medical's most recent funding round was Series B on August 25, 2025.
Who are the main investors in ProVerum Medical?
Key investors in ProVerum Medical include Lightstone Ventures, MVM Life Science Partners LLP.
Will ProVerum Medical IPO soon?
No public IPO plans have been announced for ProVerum Medical.
How can I track ProVerum Medical secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor ProVerum Medical's secondary market activity and sign up for updates.